StocksDeepDive
Snapshot · OMX Stockholm 30 · generated 2026-10-15 21:34 UTC

AZN.ST — AstraZeneca PLC

FAIR (MOS +4.0%) · Quality 68/100

Price
1675.5
Intrinsic value
1745.17
Margin of safety
+4.0%
Implied growth (reverse DCF)
+6.3%
model assumes +8.0%
Value Score
41.3
Quality
68
Psychology
-17.6
Discovery
121.3
price/volume attention only
Moat score
72.5
erosion: none

Value Score: top 18% of OMX Stockholm 30 · Quality: bottom 40%

Dividend: 31.5507/share (TTM) · yield 1.9% · payout 49%

Open the interactive Deep Dive for AZN.ST →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/AZN.ST - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is AZN.ST undervalued?

As of 2026-10-15, AZN.ST trades at 1675.5 against a computed intrinsic value of 1745.17 (+4.0% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is AstraZeneca PLC's Value Score?

AstraZeneca PLC's Value Score is 41.3 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does AZN.ST pay a dividend?

Yes - AZN.ST's trailing twelve-month dividend is 31.5507/share, a yield of 1.9% at the current price (as of 2026-10-15).